Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122394 · ClinicalTrials.gov registry record · NA
Reducing Risk of Recurrence
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT01122394: Completed NA study, sponsored by VA Office of Research and Development.
NCT01122394 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01122394, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
Adults who have had a previous stroke or transient ischemic attack (TIA) remain at risk for having a second serious event, especially if they have uncontrolled blood pressure or cholesterol. However, many patients have difficulty following treatment recommendations for lowering blood pressure and cholesterol. The purpose of this research project is to evaluate the effect of 2 booster sessions of an educational counseling intervention on how well adults who have already participated in a 6-month clinical trial had a stroke or transient ischemic attack (TIA) are able to follow a treatment plan and control their blood pressure and cholesterol levels. We will also examine how effective this intervention is in improving adherence to diet, medication, and physical activity recommendations for adults who have had a prior stroke or TIA.
Interventions
- BEHAVIORAL TI
- BEHAVIORAL AP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122394
The ClinicalTrials.gov registry entry for NCT01122394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TI is the first listed.
NCT01122394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01122394 about?
NCT01122394 is a clinical study titled "Reducing Risk of Recurrence". Adults who have had a previous stroke or transient ischemic attack (TIA) remain at risk for having a second serious event, especially if they have uncontrolled blood pressure or cholesterol. However, many patients have difficulty following treatment recommendations for lowering blood pressure and ch...
What is the current status of trial NCT01122394?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2010-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01122394?
The interventions under investigation include: TI (BEHAVIORAL), AP (BEHAVIORAL).
Who is sponsoring clinical trial NCT01122394?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.